Metformin Pharmacokinetics in Patients With Chronic and Acute Heart Failure

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 110 participants.

Also called NCT02797340

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose other
Phase
Phase 4
Enrolled
  • 110 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02797340
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Denmark (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02797340. Allocation not applicable; no masking; primary purpose other. Start 2016-01-11 (actual); primary completion 2018-04-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Metformin Pharmacokinetics in Patients With Chronic and Acute Heart Failure
Acronym
MetKin
Condition
Heart Failure, Systolic
Intervention (Other)
Blood draws and urine samples for metformin concentration measurements
Intervention (Drug)
Metformin
Lead sponsor
Aarhus University Hospital (class: other)

Record details

Record id
cardio:ct-nct02797340
Content hash
032dd3c1cdf5072326a1c851dece64c63b71cb62db60ff9c3845c85122564b58